Since 2020 Flowgy has been conducting clinical studies in the Spanish hospitals Virgen del Rocio in Seville, Arrixaca and Morales Meseguer in Murcia and the Hospital General Universitario in Valencia to determine the benefit of surgery in patients with nasal obstruction after the previous study with CFD.
Worldwide, around 7 million nasal surgeries are performed every year, of which between 40%-50% do not achieve the expected results. This situation not only represents billions in losses for the world's healthcare systems, but also leads to a considerable reduction in the quality of life of more than 3.5 million people.
Finally, after a few years of convulsion due to the pandemic and health restrictions, we are back to meet again, this time in person, at the most important congress of otolaryngology in Portugal.
Flowgy reports are a key support for ENT specialists, integrating the latest scientific advances into medical decision making.
Simulates surgical procedures to predict changes in nasal resistance, ensuring a personalized and precise approach while minimizing risks.
Flowgy SL, within the framework of the ICEX Next Program, has received support from ICEX and co-financing from the European Regional Development Fund (ERDF). The purpose of this support is to contribute to the international development of the company and its environment.
